查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1963642

臨床前影像市場：全球產業分析、規模、佔有率、成長、趨勢和預測（2025-2032）

Preclinical Imaging Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032
出版日期: | 出版商: Persistence Market Research | 英文 198 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

主要發現：

  • 臨床前影像市場規模（2025年預測）：45億美元
  • 預計市場規模（2032年）：62億美元
  • 全球市場成長率（2025年至2032年複合年成長率）：4.6%

臨床前影像市場研究範圍：

臨床前影像技術在生物醫學研究中發揮著至關重要的作用，它能夠以非侵入性的方式可視化動物模型中的生物過程。這些成像技術廣泛應用於藥物發現、疾病研究和轉化研究，使研究人員能夠即時監測疾病進展並評估治療效果。臨床前影像市場的目標客戶包括製藥公司、生物技術公司、研究機構和合約研究組織（CRO），並提供多種影像方式，包括光學影像、磁振造影（MRI）、電腦斷層掃描（CT）、正子斷層掃描（PET）和超音波系統。市場成長的促進因素包括藥物研發投入的增加、慢性病盛行率的上升以及多模態成像技術的進步，這些進步提高了研究的準確性和效率。

市場成長促進因素：

全球臨床前成像市場受多種關鍵因素驅動，其中包括藥物發現和開發領域對先進成像工具日益成長的需求。製藥和生物技術產業研發活動的不斷增加，正在加速體內影像系統在疾病機制和治療反應研究中的應用。慢性病盛行率的上升進一步增加了對有效臨床前研究模式的需求。混合成像系統和基於人工智慧的影像分析等技術進步，能夠實現更全面的數據收集和更優的研究成果，從而支持市場成長。此外，受託研究機構（CRO）的擴張也推動了臨床前影像服務外包的增加，進一步刺激了市場需求。

市場限制：

儘管臨床前成像市場前景廣闊，但仍面臨設備成本高和操作複雜等挑戰。諸如磁振造影（MRI）和正子斷層掃描（PET）等先進影像系統需要大量的資金投入和專業知識，這限制了小規模研究機構對其的採用。與動物實驗相關的監管要求和倫理問題也阻礙了市場擴張。此外，成像系統的維護成本以及對操作人員的專業要求也構成了額外的障礙，尤其是在研究基礎設施有限的發展中地區。

市場機會：

臨床前影像市場在技術創新和研究應用拓展的推動下，蘊藏著巨大的成長機會。人工智慧 (AI) 與機器學習技術與影像分析的融合，能夠提升資料解讀能力，加速藥物研發進程。結合解剖成像和功能成像的多模態成像系統的開發，為深入了解生物過程提供了更全面的視角。新興市場由於研發投入的增加和製藥業的蓬勃發展，展現出巨大的成長潛力。預計未來幾年，研究機構與產業參與者之間的策略合作將推動創新，並協助市場擴張。

本報告解答的關鍵問題：

  • 推動全球臨床前影像市場成長的關鍵因素有哪些？
  • 哪些影像技術和應用正在推動科學研究領域的應用？
  • 技術進步如何改變臨床前影像市場的競爭格局？
  • 哪些是臨床前影像市場的主要參與者？他們正在採取哪些策略來維持其市場地位？
  • 全球臨床前影像市場有哪些新興趨勢與未來前景？

目錄

第1章執行摘要

第2章 市場概覽

  • 市場範圍和定義
  • 市場動態
    • 促進要素
    • 抑制因素
    • 機會
    • 主要趨勢
  • 宏觀經濟因素
  • 新冠疫情影響分析
  • 預測因子－相關性和影響

第3章 加值見解

  • 產品導入分析
  • 監管狀態
  • 價值鏈分析
  • 重大交易和合併
  • PESTLE分析
  • 波特五力分析

第4章 定價分析，2024年

  • 主要亮點
  • 影響產品價格的關鍵因素
  • 產品價格分析
  • 區域價格和產品偏好

第5章 全球臨床前影像市場展望

  • 主要亮點
    • 市場規模（單位）預測
    • 市場規模和年成長率
    • 絕對商機
  • 市場規模分析與預測
    • 2019年至2024年市場規模表現的歷史分析
    • 市場規模分析及預測（2025-2032年）
  • 全球臨床前影像市場展望：產品
    • 引言/主要發現
    • 2019-2024年按產品分類的市場規模、表現及銷售量（單位）分析
    • 市場規模及銷售量（單位）分析及預測（依產品分類），2025-2032 年
      • 影像系統
      • 試劑
      • 軟體和服務
    • 產品市場吸引力分析
  • 全球臨床前影像市場按影像方式展望
    • 引言/主要發現
    • 依治療方式分類的市場規模表現分析，2019-2024 年
    • 依治療方式分類的市場規模分析及預測（2025-2032年）
      • 光學成像
      • 核分子影像
      • 微型磁振造影
      • 微超音波
      • 微型CT
      • 光聲成像（PAT）
      • 磁粒子成像
      • 其他
    • 按模式分類的市場吸引力分析
  • 全球臨床前成像市場展望（按應用領域分類）
    • 引言/主要發現
    • 按應用領域分類的市場規模績效分析（2019-2024 年）
    • 按應用領域分類的市場規模分析與預測（2025-2032年）
      • 研究與開發
      • 藥物發現與開發
    • 按應用領域進行市場吸引力分析
  • 全球臨床前成像市場展望（按最終用戶分類）
    • 引言/主要發現
    • 按最終用戶分類的市場規模績效分析，2019-2024 年
    • 依最終用戶分類的市場規模分析及預測（2025-2032 年）
      • 製藥和生物技術公司
      • 學術和研究機構
      • 診斷影像中心
      • 其他
    • 最終用戶市場吸引力分析

6. 全球臨床前影像市場區域展望

  • 主要亮點
  • 2019年至2024年各地區市場規模表現分析
  • 市場規模分析及預測（依地區分類，2025-2032年）
    • 北美洲
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 拉丁美洲
    • 中東和非洲
  • 按地區分類的市場吸引力分析

7. 北美臨床前影像市場展望

8. 歐洲臨床前影像市場展望

9. 東亞臨床前影像市場展望

10. 南亞和大洋洲臨床前影像市場展望

11. 拉丁美洲臨床前影像市場展望

12. 中東和非洲臨床前影像市場展望

第13章 競爭格局

  • 2024年市佔率分析
  • 市場結構
    • 市場競爭格局分析
    • 競爭對手儀錶板
  • 公司簡介（詳情 - 概述、財務狀況、策略、近期發展）
    • Bruker
    • Siemens Healthcare Private Limited
    • Revvity
    • FUJIFILM VisualSonics, Inc.
    • Scintica
    • MILabs BV
    • United Imaging Healthcare Co., Ltd.
    • Mediso Ltd.
    • Aspect Imaging Ltd.
    • Inviscan Imaging Systems
    • TriFoil Imaging
    • Southern Scientific Ltd.
    • Iconeus
    • MR Solutions
    • BioPAL, Inc.
    • Viscover

第14章附錄

簡介目錄
Product Code: PMRREP34717

Persistence Market Research has recently released a comprehensive report on the worldwide market for preclinical imaging. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global preclinical imaging market from 2025 to 2032.

Key Insights:

  • Preclinical Imaging Market Size (2025E): USD 4.5 Billion
  • Projected Market Value (2032F): USD 6.2 Billion
  • Global Market Growth Rate (CAGR 2025 to 2032): 4.6%

Preclinical Imaging Market - Report Scope:

Preclinical imaging plays a crucial role in biomedical research by enabling non-invasive visualization of biological processes in animal models. These imaging technologies are widely used in drug discovery, disease research, and translational studies, allowing researchers to monitor disease progression and evaluate therapeutic responses in real time. The preclinical imaging market caters to pharmaceutical and biotechnology companies, research institutions, and contract research organizations, offering a range of imaging modalities such as optical imaging, MRI, CT, PET, and ultrasound systems. Market growth is driven by increasing investments in pharmaceutical research, rising prevalence of chronic diseases, and advancements in multimodal imaging technologies that improve research accuracy and efficiency.

Market Growth Drivers:

The global preclinical imaging market is propelled by several key factors, including the growing demand for advanced imaging tools in drug discovery and development. Increasing research and development activities in pharmaceutical and biotechnology industries have accelerated the adoption of in vivo imaging systems for studying disease mechanisms and therapeutic responses. The rising prevalence of chronic diseases has further increased the need for effective preclinical research models. Technological advancements, including hybrid imaging systems and AI-powered image analysis, enable more comprehensive data acquisition and improved research outcomes, supporting market growth. Additionally, the expansion of contract research organizations contributes to increased outsourcing of preclinical imaging services, further driving market demand.

Market Restraints:

Despite promising growth prospects, the preclinical imaging market faces challenges related to high equipment costs and operational complexity. Advanced imaging systems such as MRI and PET scanners require significant capital investment and specialized expertise, limiting adoption among smaller research facilities. Regulatory requirements and ethical concerns related to animal testing also present challenges for market expansion. Furthermore, maintenance costs and the need for skilled professionals to operate imaging systems create additional barriers, particularly in developing regions with limited research infrastructure.

Market Opportunities:

The preclinical imaging market presents significant growth opportunities driven by technological innovations and expanding research applications. The integration of artificial intelligence and machine learning in imaging analysis enhances data interpretation and accelerates drug discovery processes. The development of multimodal imaging systems that combine anatomical and functional imaging capabilities provides comprehensive insights into biological processes. Emerging markets offer substantial growth potential due to increasing research investments and expanding pharmaceutical industries. Strategic collaborations between research institutions and industry players are expected to foster innovation and support market expansion in the coming years.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the preclinical imaging market globally?
  • Which imaging modalities and applications are driving adoption across research settings?
  • How are technological advancements reshaping the competitive landscape of the preclinical imaging market?
  • Who are the key players contributing to the preclinical imaging market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global preclinical imaging market?

Competitive Intelligence and Business Strategy:

Leading players in the global preclinical imaging market focus on technological innovation, product development, and strategic collaborations to strengthen their market position. Companies invest in advanced imaging solutions, including multimodal and high-resolution imaging systems, to meet evolving research requirements. Partnerships with pharmaceutical companies and research institutions facilitate product adoption and expand market reach. Emphasis on software integration and AI-powered analytics further enhances imaging efficiency and research outcomes, enabling companies to maintain competitiveness in a rapidly evolving market landscape.

Key Companies Profiled:

  • Bruker
  • Siemens Healthcare Private Limited
  • Revvity
  • FUJIFILM VisualSonics, Inc.
  • Scintica
  • MILabs B.V.
  • Mediso Ltd.
  • Aspect Imaging Ltd.
  • MR Solutions
  • TriFoil Imaging
  • United Imaging Healthcare Co., Ltd.
  • BioPAL, Inc.

Preclinical Imaging Market Research Segmentation:

By Product:

  • Imaging Systems
  • Reagents
  • Software
  • Services

By Modality:

  • Optical Imaging
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • Positron Emission Tomography (PET)
  • Ultrasound Imaging
  • Others

By Application:

  • Drug Discovery and Development
  • Oncology Research
  • Neurology Research
  • Cardiology Research
  • Inflammation and Infectious Disease Research
  • Others

By End-User:

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organizations
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Preclinical Imaging Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Price Analysis, 2024A

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Product Prices
  • 4.3. Pricing Analysis, By Product
  • 4.4. Regional Prices and Product Preferences

5. Global Preclinical Imaging Market Outlook

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Bn) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019 - 2024
    • 5.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
  • 5.3. Global Preclinical Imaging Market Outlook: Product
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product, 2019 - 2024
    • 5.3.3. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
      • 5.3.3.1. Imaging Systems
      • 5.3.3.2. Reagents
      • 5.3.3.3. Software & Services
    • 5.3.4. Market Attractiveness Analysis: Product
  • 5.4. Global Preclinical Imaging Market Outlook: Modality
    • 5.4.1. Introduction / Key Findings
    • 5.4.2. Historical Market Size (US$ Bn) Analysis, By Modality, 2019 - 2024
    • 5.4.3. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
      • 5.4.3.1. Optical Imaging
      • 5.4.3.2. Nuclear Molecular Imaging
      • 5.4.3.3. Micro MRI
      • 5.4.3.4. Micro Ultrasound
      • 5.4.3.5. Micro CT
      • 5.4.3.6. Photoacoustic Tomography (PAT)
      • 5.4.3.7. Magnetic Particle Imaging
      • 5.4.3.8. Others
    • 5.4.4. Market Attractiveness Analysis: Modality
  • 5.5. Global Preclinical Imaging Market Outlook: Application
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019 - 2024
    • 5.5.3. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
      • 5.5.3.1. Research & Development
      • 5.5.3.2. Drug Discovery & Development
    • 5.5.4. Market Attractiveness Analysis: Application
  • 5.6. Global Preclinical Imaging Market Outlook: End User
    • 5.6.1. Introduction / Key Findings
    • 5.6.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019 - 2024
    • 5.6.3. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
      • 5.6.3.1. Pharmaceutical and Biotech Companies
      • 5.6.3.2. Academic and Research Institutes
      • 5.6.3.3. Imaging Centers
      • 5.6.3.4. Others
    • 5.6.4. Market Attractiveness Analysis: End User

6. Global Preclinical Imaging Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019 - 2024
  • 6.3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Preclinical Imaging Market Outlook

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Modality
    • 7.2.4. By Application
    • 7.2.5. By End User
  • 7.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 7.4.1. Imaging Systems
    • 7.4.2. Reagents
    • 7.4.3. Software & Services
  • 7.5. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 7.5.1. Optical Imaging
    • 7.5.2. Nuclear Molecular Imaging
    • 7.5.3. Micro MRI
    • 7.5.4. Micro Ultrasound
    • 7.5.5. Micro CT
    • 7.5.6. Photoacoustic Tomography (PAT)
    • 7.5.7. Magnetic Particle Imaging
    • 7.5.8. Others
  • 7.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 7.6.1. Research & Development
    • 7.6.2. Drug Discovery & Development
  • 7.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 7.7.1. Pharmaceutical and Biotech Companies
    • 7.7.2. Academic and Research Institutes
    • 7.7.3. Imaging Centers
    • 7.7.4. Others
  • 7.8. Market Attractiveness Analysis

8. Europe Preclinical Imaging Market Outlook

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Modality
    • 8.2.4. By Application
    • 8.2.5. By End User
  • 8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 8.4.1. Imaging Systems
    • 8.4.2. Reagents
    • 8.4.3. Software & Services
  • 8.5. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 8.5.1. Optical Imaging
    • 8.5.2. Nuclear Molecular Imaging
    • 8.5.3. Micro MRI
    • 8.5.4. Micro Ultrasound
    • 8.5.5. Micro CT
    • 8.5.6. Photoacoustic Tomography (PAT)
    • 8.5.7. Magnetic Particle Imaging
    • 8.5.8. Others
  • 8.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 8.6.1. Research & Development
    • 8.6.2. Drug Discovery & Development
  • 8.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 8.7.1. Pharmaceutical and Biotech Companies
    • 8.7.2. Academic and Research Institutes
    • 8.7.3. Imaging Centers
    • 8.7.4. Others
  • 8.8. Market Attractiveness Analysis

9. East Asia Preclinical Imaging Market Outlook

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Modality
    • 9.2.4. By Application
    • 9.2.5. By End User
  • 9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 9.4.1. Imaging Systems
    • 9.4.2. Reagents
    • 9.4.3. Software & Services
  • 9.5. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 9.5.1. Optical Imaging
    • 9.5.2. Nuclear Molecular Imaging
    • 9.5.3. Micro MRI
    • 9.5.4. Micro Ultrasound
    • 9.5.5. Micro CT
    • 9.5.6. Photoacoustic Tomography (PAT)
    • 9.5.7. Magnetic Particle Imaging
    • 9.5.8. Others
  • 9.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 9.6.1. Research & Development
    • 9.6.2. Drug Discovery & Development
  • 9.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 9.7.1. Pharmaceutical and Biotech Companies
    • 9.7.2. Academic and Research Institutes
    • 9.7.3. Imaging Centers
    • 9.7.4. Others
  • 9.8. Market Attractiveness Analysis

10. South Asia & Oceania Preclinical Imaging Market Outlook

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Modality
    • 10.2.4. By Application
    • 10.2.5. By End User
  • 10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 10.4.1. Imaging Systems
    • 10.4.2. Reagents
    • 10.4.3. Software & Services
  • 10.5. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 10.5.1. Optical Imaging
    • 10.5.2. Nuclear Molecular Imaging
    • 10.5.3. Micro MRI
    • 10.5.4. Micro Ultrasound
    • 10.5.5. Micro CT
    • 10.5.6. Photoacoustic Tomography (PAT)
    • 10.5.7. Magnetic Particle Imaging
    • 10.5.8. Others
  • 10.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 10.6.1. Research & Development
    • 10.6.2. Drug Discovery & Development
  • 10.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 10.7.1. Pharmaceutical and Biotech Companies
    • 10.7.2. Academic and Research Institutes
    • 10.7.3. Imaging Centers
    • 10.7.4. Others
  • 10.8. Market Attractiveness Analysis

11. Latin America Preclinical Imaging Market Outlook

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Modality
    • 11.2.4. By Application
    • 11.2.5. By End User
  • 11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 11.4.1. Imaging Systems
    • 11.4.2. Reagents
    • 11.4.3. Software & Services
  • 11.5. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 11.5.1. Optical Imaging
    • 11.5.2. Nuclear Molecular Imaging
    • 11.5.3. Micro MRI
    • 11.5.4. Micro Ultrasound
    • 11.5.5. Micro CT
    • 11.5.6. Photoacoustic Tomography (PAT)
    • 11.5.7. Magnetic Particle Imaging
    • 11.5.8. Others
  • 11.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 11.6.1. Research & Development
    • 11.6.2. Drug Discovery & Development
  • 11.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 11.7.1. Pharmaceutical and Biotech Companies
    • 11.7.2. Academic and Research Institutes
    • 11.7.3. Imaging Centers
    • 11.7.4. Others
  • 11.8. Market Attractiveness Analysis

12. Middle East & Africa Preclinical Imaging Market Outlook

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 12.2.1. By Country
    • 12.2.2. By Product
    • 12.2.3. By Modality
    • 12.2.4. By Application
    • 12.2.5. By End User
  • 12.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 12.4.1. Imaging Systems
    • 12.4.2. Reagents
    • 12.4.3. Software & Services
  • 12.5. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 12.5.1. Optical Imaging
    • 12.5.2. Nuclear Molecular Imaging
    • 12.5.3. Micro MRI
    • 12.5.4. Micro Ultrasound
    • 12.5.5. Micro CT
    • 12.5.6. Photoacoustic Tomography (PAT)
    • 12.5.7. Magnetic Particle Imaging
    • 12.5.8. Others
  • 12.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 12.6.1. Research & Development
    • 12.6.2. Drug Discovery & Development
  • 12.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 12.7.1. Pharmaceutical and Biotech Companies
    • 12.7.2. Academic and Research Institutes
    • 12.7.3. Imaging Centers
    • 12.7.4. Others
  • 12.8. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Bruker
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Product
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Siemens Healthcare Private Limited
    • 13.3.3. Revvity
    • 13.3.4. FUJIFILM VisualSonics, Inc.
    • 13.3.5. Scintica
    • 13.3.6. MILabs B.V.
    • 13.3.7. United Imaging Healthcare Co., Ltd.
    • 13.3.8. Mediso Ltd.
    • 13.3.9. Aspect Imaging Ltd.
    • 13.3.10. Inviscan Imaging Systems
    • 13.3.11. TriFoil Imaging
    • 13.3.12. Southern Scientific Ltd.
    • 13.3.13. Iconeus
    • 13.3.14. MR Solutions
    • 13.3.15. BioPAL, Inc.
    • 13.3.16. Viscover

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations